Topical fluorouracil after surgery for ocular surface squamous neoplasia in Kenya: a randomised, double-blind, placebo-controlled trial

[1]  H. Bouguila,et al.  [Prognosis of primary malignant tumors of the conjunctiva]. , 2015, Journal francais d'ophtalmologie.

[2]  W. Dean,et al.  Ocular surface squamous neoplasia in HIV-positive and HIV-negative patients and response to 5-fluorouracil in Angola , 2014, Clinical ophthalmology.

[3]  M. Burton,et al.  Pathophysiology of ocular surface squamous neoplasia , 2014, Experimental eye research.

[4]  J. Muecke,et al.  Long‐term outcomes after adjunctive topical 5‐flurouracil or mitomycin C for the treatment of surgically excised, localized ocular surface squamous neoplasia , 2014, Clinical & experimental ophthalmology.

[5]  B. Kahan.  Accounting for centre-effects in multicentre trials with a binary outcome – when, why, and how? , 2014, BMC Medical Research Methodology.

[6]  H. Weiss,et al.  Epidemiology of ocular surface squamous neoplasia in Africa , 2013, Tropical medicine & international health : TM & IH.

[7]  Sander R. Dubovy,et al.  Predictors of ocular surface squamous neoplasia recurrence after excisional surgery. , 2012, Ophthalmology.

[8]  K. Fielding,et al.  Early loss to follow-up of recently diagnosed HIV-infected adults from routine pre-ART care in a rural district hospital in Kenya: a cohort study , 2011, Tropical medicine & international health : TM & IH.

[9]  J. Muecke,et al.  Adjuvant 5-fluorouracil in the treatment of localised ocular surface squamous neoplasia , 2011, British Journal of Ophthalmology.

[10]  K. Goins,et al.  Treatment of Ocular Surface Squamous Cell Intraepithelial Neoplasia With and Without Mitomycin C , 2011, Cornea.

[11]  E. Midena,et al.  Topical 1% 5-fluorouracil in ocular surface squamous neoplasia: a long-term safety study , 2010, British Journal of Ophthalmology.

[12]  A. Al-Barrag,et al.  5-Fluorouracil for the treatment of intraepithelial neoplasia and squamous cell carcinoma of the conjunctiva, and cornea , 2010, Clinical ophthalmology.

[13]  D. Lockington,et al.  Topical mitomycin C chemotherapy in the management of ocular surface neoplasia: a 10-year review of treatment outcomes and complications , 2010, British Journal of Ophthalmology.

[14]  R. Weber,et al.  Social Challenges of Cancer Patients With Orbitofacial Disfigurement , 2010, Ophthalmic plastic and reconstructive surgery.

[15]  A. Zaki,et al.  Management of Intraepithelial and Invasive Neoplasia of the Cornea and Conjunctiva: A Long-Term Follow Up , 2009, Cornea.

[16]  C. Bekibele,et al.  Intraepithelial and invasive squamous neoplasms of the conjunctiva in Ibadan, Nigeria: a clinicopathological study of 46 cases , 2009, International Ophthalmology.

[17]  L. Hirst.  Randomized controlled trial of topical mitomycin C for ocular surface squamous neoplasia: early resolution. , 2007, Ophthalmology.

[18]  K. Waddell,et al.  Corneo-conjunctival carcinoma in Uganda , 2006, Eye.

[19]  M. Kollmann,et al.  Conjunctival squamous cell carcinoma in patients with human immunodeficiency virus infection seen at two hospitals in Kenya. , 2006, East African medical journal.

[20]  J. Pe’er.  Ocular surface squamous neoplasia. , 2005, Ophthalmology clinics of North America.

[21]  P. Johnston,et al.  5-Fluorouracil: mechanisms of action and clinical strategies , 2003, Nature Reviews Cancer.

[22]  R. Yeatts,et al.  5-Fluorouracil for the treatment of intraepithelial neoplasia of the conjunctiva and cornea. , 2000, Ophthalmology.

[23]  E. Cohen,et al.  Surgical Management of Ocular Surface Squamous Neoplasms: The Experience From a Cornea Center , 2000, Cornea.

[24]  P. Boccato,et al.  Treatment of conjunctival squamous cell carcinoma with topical 5-fluorouracil , 2000, The British journal of ophthalmology.

[25]  G. Snibson,et al.  Late recurrences and the necessity for long-term follow-up in corneal and conjunctival intraepithelial neoplasia. , 1997, Ophthalmology.

[26]  R. Hitchings,et al.  Racial differences in the results of glaucoma filtration surgery: are racial differences in the conjunctival cell profile important? , 1994, The British journal of ophthalmology.

[27]  B. Dhillon,et al.  The management of cytomegalovirus retinitis in AIDS. , 1994, The British journal of ophthalmology.

[28]  V. Curtin,et al.  Conjunctival Squamous Cell Carcinoma in Patients with Human Immunodeficiency Virus Infection , 1990 .

[29]  K. Mrad,et al.  [Prognosis of primary malignant tumors of the conjunctiva]. , 2015, Journal francais d'ophtalmologie.

[30]  R. Casson,et al.  The Clinical Applications of Fluorouracil in Ophthalmic Practice , 2012, Drugs.

[31]  J. Irlam,et al.  Interventions for squamous cell carcinoma of the conjunctiva in HIV-infected individuals. , 2007, The Cochrane database of systematic reviews.

[32]  C. Shields,et al.  Tumors of the conjunctiva and cornea. , 2004, Survey of ophthalmology.